Literature DB >> 28868342

PSMA redirects MAPK to PI3K-AKT signaling to promote prostate cancer progression.

Leslie Ann Caromile1, Linda H Shapiro1.   

Abstract

Increased Prostate Specific Membrane Antigen expression promotes tumor progression in prostate epithelium by dysregulating the β1-integrin/type I insulin-like growth factor receptor axis, resulting in a shift in signaling from the less aggressive mitogen-activated protein kinase-extracellular signal-regulated kinases 1 and 2 pathway to the pro-survival protein kinase B(AKT)/phosphatidylinositol 3-kinase pathway.

Entities:  

Keywords:  MAPK; PI3K-AKT; PSMA; Prostate Cancer; Tumor

Year:  2017        PMID： 28868342      PMCID： PMC5540209          DOI： 10.1080/23723556.2017.1321168

Source DB:  PubMed          Journal:  Mol Cell Oncol        ISSN： 2372-3556


  10 in total

1.  Trop-2 inhibits prostate cancer cell adhesion to fibronectin through the β1 integrin-RACK1 axis.

Authors:  Marco Trerotola; Jing Li; Saverio Alberti; Lucia R Languino
Journal:  J Cell Physiol       Date:  2012-11       Impact factor: 6.384

2.  PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer.

Authors:  Leslie Ann Caromile; Kristina Dortche; M Mamunur Rahman; Christina L Grant; Christopher Stoddard; Fernando A Ferrer; Linda H Shapiro
Journal:  Sci Signal       Date:  2017-03-14       Impact factor: 8.192

3.  Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: a novel folate hydrolase.

Authors:  W D Heston
Journal:  Urology       Date:  1997-03       Impact factor: 2.649

4.  Prostate specific membrane antigen produces pro-angiogenic laminin peptides downstream of matrix metalloprotease-2.

Authors:  Rebecca E Conway; Kyle Joiner; Alex Patterson; David Bourgeois; Robert Rampp; Benjamin C Hannah; Samantha McReynolds; John M Elder; Hannah Gilfilen; Linda H Shapiro
Journal:  Angiogenesis       Date:  2013-06-18       Impact factor: 9.596

5.  Deletion of the glutamate carboxypeptidase II gene in mice reveals a second enzyme activity that hydrolyzes N-acetylaspartylglutamate.

Authors:  Dean J Bacich; Epolia Ramadan; Denise S O'Keefe; Noreen Bukhari; Iga Wegorzewska; Olumide Ojeifo; Rafal Olszewski; Craige C Wrenn; Tomasz Bzdega; Barbara Wroblewska; Warren D W Heston; Joseph H Neale
Journal:  J Neurochem       Date:  2002-10       Impact factor: 5.372

Review 6.  Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer.

Authors:  Philip A Watson; Vivek K Arora; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2015-11-13       Impact factor: 60.716

7.  Insulin-like growth factor-I receptor mediates the prosurvival effect of fibronectin.

Authors:  Mouad Edderkaoui; Peggy Hong; Jong K Lee; Stephen J Pandol; Anna S Gukovskaya
Journal:  J Biol Chem       Date:  2007-07-12       Impact factor: 5.157

8.  Prostate specific membrane antigen (PSMA) regulates angiogenesis independently of VEGF during ocular neovascularization.

Authors:  Christina L Grant; Leslie A Caromile; Vivienne Ho; Khayyam Durrani; M Mamunur Rahman; Kevin P Claffey; Guo-Hua Fong; Linda H Shapiro
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

9.  Targeted inhibition of prostate cancer metastases with an RNA aptamer to prostate-specific membrane antigen.

Authors:  Justin P Dassie; Luiza I Hernandez; Gregory S Thomas; Matthew E Long; William M Rockey; Craig A Howell; Yani Chen; Frank J Hernandez; Xiu Ying Liu; Mary E Wilson; Lee-Ann Allen; Daniel A Vaena; David K Meyerholz; Paloma H Giangrande
Journal:  Mol Ther       Date:  2014-06-23       Impact factor: 11.454

Review 10.  IGF-1R as an anti-cancer target--trials and tribulations.

Authors:  Helen X Chen; Elad Sharon
Journal:  Chin J Cancer       Date:  2013-04-19
  10 in total
  5 in total

1.  Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy.

Authors:  Mark C Markowski; Pedro Isaacsson Velho; Mario A Eisenberger; Martin G Pomper; Kenneth J Pienta; Michael A Gorin; Emmanuel S Antonarakis; Samuel R Denmeade; Steven P Rowe
Journal:  J Nucl Med       Date:  2021-01-15       Impact factor: 10.057

2.  Expression of Prostate Specific Membrane Antigen (PSMA) in Breast Cancer.

Authors:  Clara Unger; Peter Bronsert; Kerstin Michalski; Anna Bicker; Ingolf Juhasz-Böss
Journal:  Geburtshilfe Frauenheilkd       Date:  2022-01-10       Impact factor: 2.915

3.  MicroRNA-30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3.

Authors:  Xin-Min Zheng; Peng Zhang; Man-Hua Liu; Ping Chen; Wei-Bing Zhang
Journal:  Int J Oncol       Date:  2018-11-26       Impact factor: 5.650

4.  Insulin-like Growth Factor-1 Influences Prostate Cancer Cell Growth and Invasion through an Integrin α3, α5, αV, and β1 Dependent Mechanism.

Authors:  Carolin Siech; Jochen Rutz; Sebastian Maxeiner; Timothy Grein; Marlon Sonnenburg; Igor Tsaur; Felix K-H Chun; Roman A Blaheta
Journal:  Cancers (Basel)       Date:  2022-01-12       Impact factor: 6.639

5.  PSMA Expression in 122 Treatment Naive Glioma Patients Related to Tumor Metabolism in 11C-Methionine PET and Survival.

Authors:  Tatjana Traub-Weidinger; Nina Poetsch; Adelheid Woehrer; Eva-Maria Klebermass; Tatjana Bachnik; Matthias Preusser; Mario Mischkulnig; Barbara Kiesel; Georg Widhalm; Markus Mitterhauser; Marcus Hacker; Oskar Koperek
Journal:  J Pers Med       Date:  2021-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.